Skip to main content
spacbrain

Sorrento Therapeutics, Inc.

CIK 0000850261

2 SPACs with a current declared position, filed between Sep 26, 2023 and Oct 5, 2023. 0 of them were re-affirmed in the last 12 months. The rest are the filer’s last word on a position, not proof it is still held: an amendment is only required on a material change, so a fund that sells below 5% may never file again.

This filer has not filed a Schedule 13 on any SPAC since Oct 5, 2023. Read the page below as a record of what was declared, not as a register of what is held.

Filed under 1 earlier name

QUIKBYTE SOFTWARE INCEDGAR’s own former-name record for CIK 0000850261. The page did not move when the filer renamed, because the identity is the CIK and the URL is a label it owns.

SPACs declared
2
every position whose latest statement stands — the record
Re-affirmed in 12 months
0
filed inside 365 days — what a reader means by "owns"
Still live
0
positions in SPACs still searching or in an announced deal
Median stake
2.0%
no percentage stated on the cover pages
1 passive (13G)1 activist (13D)5 superseded statements on file

Positions

one row per SPAC — every figure read from the accession in the Source column
2 of 2 shown · 2 positions have not been amended in over a year
SPACVotingDispositiveSource
GXGXGX Acquisition Corp.2.6%5,050,4275,050,427 / 05,050,427 / 0Closed (deSPAC)Oct 5, 2023StaleSC 13G/A0001104659-23-107269 opens on sec.gov in a new tab1 earlier statement
VCKAScilex Holding Co1.3%1,917,2101,917,210 / 01,917,210 / 0Closed (deSPAC)Sep 26, 2023StaleSC 13D/A · may seek to influence control0001104659-23-103904 opens on sec.gov in a new tab4 earlier statements
5 superseded statements

An amendment replaces a stake as current; it never erases the record of it. These are the earlier statements, each with the accession that replaced it — kept because “what did this filer say in 2022” is a different question from “what does it say now”, and only the second one has an answer above.

  • VCKA Scilex Holding Co43.3% · SC 13D/A Aug 15, 2023replaced Sep 26, 2023 by 0001104659-23-103904
  • VCKA Scilex Holding Co44.2% · SC 13D/A Mar 3, 2023replaced Aug 15, 2023 by 0001193125-23-212733
  • VCKA Scilex Holding Co45.5% · SC 13D/A Jan 23, 2023replaced Mar 3, 2023 by 0001193125-23-059136
  • VCKA Scilex Holding Co96.3% · SC 13D Nov 17, 2022replaced Jan 23, 2023 by 0001193125-23-013193
  • GXGX GX Acquisition Corp.16.7% · SC 13G Jul 23, 2021replaced Oct 5, 2023 by 0001104659-23-107269

Appears alongside

other filers with a current declared position in the same SPACs

Co-occurrence in the disclosure record, and nothing more. It is not evidence of a group, an agreement or acting in concert — filers who act as a group say so on the cover page and file a 13D. Two arbitrage funds above 5% in the same shell is the ordinary shape of this market. The second number restricts both sides to statements filed in the last 12 months, because a 2021 stake beside a 2026 one is two facts about two different years.

Every percentage above is the one printed on the cover page of the filing cited beside it — a percentage of the shares outstanding on that date. A SPAC’s float collapses at each redemption, so two of these percentages are percentages of two different companies and they do not add. Rows are one per SPAC: where a joint schedule names several reporting persons, the largest single figure is shown rather than their sum, because a manager and the funds it advises beneficially own the same shares. Nothing on this page is derived from a 13F, a vendor holdings file or a press release. See how this is built.